Search

  • Home
  • About
  • Products

      • Hematopoietic Stem Cells (HSCs)

        • HuSu-TRANS-HSC-CB-MNC
        • HuSu-TRANS-HSC-PBCD34+
        • HuSu-TRANS-HSC-CBCD34+
        • TRANS-HSC-PB-MNC
        • View Category >

      • Mesenchymal Stem Cells (MSCs)

        • HuSu-TRANS-MSC
        • HuSu-TRANSCHYMAL™ – DP
        • HuSu-TRANSCHYMAL™ – UC
        • HuSu-TRANSCHYMAL™ – AD
        • View Category >

      • Tumor Tissue Model

        • Human Tumour Tissue, Frozen

      • Reconstructed Tissue

        • TRANSKIN

      • Primary Cancer Cells

        • HuSu-TRANS -TR-C
        • HuSu-TRANS -TR-O
        • HuSu-TRANS -TR-H&N
        • HuSu-TRANS-TR-B
        • View Category >

      • Cruelty Free Workstation Solutions

        • NeuroSAFE
  • COVID-19
    • CD34+ Configured Cellular Platform
    • iPSCs, Frozen
  • Communications
    • Media
    • Publications
    • Events
  • Applications
  • Blog
    • All Articles
    • Stemcell
    • In-vivo
    • Others
  • Contact
  • Order Tracking
  • login
New platform for testing COVID-19 vaccines & drug candidates.
0
New platform for testing COVID-19 vaccines & drug candidates.
  • Order Tracking
  • login
Transcell Transcell Transcell
0

Cart (0)

  • Home
  • About
  • Products

      • Hematopoietic Stem Cells (HSCs)

        • HuSu-TRANS-HSC-CB-MNC
        • HuSu-TRANS-HSC-PBCD34+
        • HuSu-TRANS-HSC-CBCD34+
        • TRANS-HSC-PB-MNC
        • View Category >

      • Mesenchymal Stem Cells (MSCs)

        • HuSu-TRANS-MSC
        • HuSu-TRANSCHYMAL™ – DP
        • HuSu-TRANSCHYMAL™ – UC
        • HuSu-TRANSCHYMAL™ – AD
        • View Category >

      • Tumor Tissue Model

        • Human Tumour Tissue, Frozen

      • Reconstructed Tissue

        • TRANSKIN

      • Primary Cancer Cells

        • HuSu-TRANS -TR-C
        • HuSu-TRANS -TR-O
        • HuSu-TRANS -TR-H&N
        • HuSu-TRANS-TR-B
        • View Category >

      • Cruelty Free Workstation Solutions

        • NeuroSAFE
  • COVID-19
    • CD34+ Configured Cellular Platform
    • iPSCs, Frozen
  • Communications
    • Media
    • Publications
    • Events
  • Applications
  • Blog
    • All Articles
    • Stemcell
    • In-vivo
    • Others
  • Contact
Home > Uncategorized > TranstoxBio’s New Platform For Testing Covid-19 Vaccines and Drug Candidates

TranstoxBio’s New Platform For Testing Covid-19 Vaccines and Drug Candidates

June 30, 2020 transcell-admin
TranstoxBio’s New Platform For Testing Covid-19 Vaccines and Drug Candidates.

June 30, 2020

News Update on Transcell Oncologics Announces New Portfolio Transtoxbio Testing

Share:

Categories

  • In-vivo
  • Stemcell
  • Uncategorized

Related Posts
Human-derived in vitro systems for cosmetics testing- the status and the road ahead
November 4, 2020 subhadra
PRIMATES – NO MORE A MODEL TO TEST VACCINES
August 31, 2020 transcell-admin
Transcell Oncologics brings unique portfolio for COVID-19 vaccines & drug candidates
June 19, 2020 transcell-admin
Biotech Express Transtoxbio Article
March 19, 2020 transcell-admin
News Update on Transcell Oncologics’s Cell Based Platforms Portfolio Onboarding Channel Partner For New Geographies
March 18, 2020 transcell-admin

8th Floor, Western Pearl,
Hitec City Road, Kondapur, Hyderabad 500084, TG, India.
info@transtoxbio.com

Contact US

Social Icons

  • Facebook
  • LinkedIn
  • Twitter
Need help

phone-icon 1-908-325-2508

Monday – Friday: 9:00-20:00
Saturday: 11:00 – 15:00

Product Queries: info@transtoxbio.com
Business Queries: enquiry@transtoxbio.com

Information
  • About us
  • Our Blog
  • Events
  • Publications
  • Media
  • Privacy Policy
Store
  • COVID 19
  • HSCs
  • MSCs
  • Tumor Tissue Model
  • Reconstructed Tissue
  • Primary Cancer Cells

Copyright © 2020 Transcell Oncologics. All Rights Reserved

Back to Top
Product has been added to your cart
Close